Home Stock

Stock Research: West Pharmaceutical Services

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

West Pharmaceutical Services

NYQ:WST US9553061055
76
  • Value
    50
  • Growth
    45
  • Safety
    Safety
    100
  • Combined
    73
  • Sentiment
    73
  • 360° View
    360° View
    76
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

West Pharmaceutical Services, Inc. designs and manufactures containment and delivery systems for injectable drugs. The company operates in the pharmaceutical, diagnostic, and medical device industries. It is a global company. In the last fiscal year, the company had a market cap of $15,881 million, profits of $1 million, and revenue of $3 million, with 10600 employees.

more

ANALYSIS: With an Obermatt 360° View of 76 (better than 76% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock West Pharmaceutical Services are very positive. The 360° View is based on consolidating four consolidated indicators, with half of the indicators below and half above average for West Pharmaceutical Services. The consolidated Value Rank has an attractive rank of 50, which means that the share price of West Pharmaceutical Services is on the lower side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 50% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 100. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 73. But the consolidated Growth Rank has a low rank of 45, which means that the company is below average in terms of growth and momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. 55 of its competitors have better growth. ...read more

more
Strongest Rank Capital Growth
Weakest Rank Safety
Country USA
Industry Life Sciences Tools & Services
Size Large
Website westpharma.com
Index
D.J. US Health Care
S&P 500
West Pharmaceutical Services stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 11-Nov-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
50 48 26 57
Growth
45 12 65 81
Safety
Safety
100 100 93 85
Sentiment
73 56 86 93
360° View
360° View
76 76 89 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
48 78 67 36
Opinions Change
20 7 50 91
Pro Holdings
n/a 47 69 69
Market Pulse
73 71 87 72
Sentiment
73 56 86 93
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
50 48 26 57
Growth
45 12 65 81
Safety Safety
100 100 93 85
Combined
73 44 73 95
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
23 31 13 31
Price vs. Earnings (P/E)
15 18 18 24
Price vs. Book (P/B)
32 23 9 14
Dividend Yield
95 84 79 86
Value
50 48 26 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
56 54 63 37
Profit Growth
89 18 42 86
Capital Growth
7 9 12 39
Stock Returns
72 22 93 83
Growth
45 12 65 81
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for more than 8,000 stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
78 72 64 58
Refinancing
63 20 25 25
Liquidity
100 100 100 98
Safety Safety
100 100 93 85

Similar Stocks

Discover high‑ranked alternatives to West Pharmaceutical Services and broaden your portfolio horizons.

Toll Brothers

NYQ:TOL
Country: USA
Industry: Homebuilding
Size: X-Large
Full Stock Analysis

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Bunge

NYQ:BG
Country: USA
Industry: Agricultural Products
Size: X-Large
Full Stock Analysis

Cognizant Technology

NSQ:CTSH
Country: USA
Industry: IT Consulting & oth. Services
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

The stock offers good value, safe financing, and positive sentiment. However, it has below-average growth expectations. It is well-suited for conservative buy-and-hold investors who prioritize stability and low valuation over growth.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews